LOUIS TARTAGLIA

Profile

First Name

: LOUIS

Middle Name

:

Last Name

: TARTAGLIA

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER, DIRECTOR

EMBER THERAPEUTICS, INC.

MITCHELL BLOOM, KEVIN GILLIS, DAN LYNCH, BRUCE SPIEGELMAN

DIRECTOR

SOLSTICE BIOLOGICS LLC

ROBERT ADELMAN, JOHN BORGESON, CURT BRADSHAW, STEVEN DOWDY, COREY GOODMAN, FRANK MUHLENBECK, GEORGE REHM

EXECUTIVE OFFICER, DIRECTOR

CYCLOPORTERS, INC.

CHRISTINE BRENNAN, JOHN CROWLEY, JOHN F. CROWLEY, DIPAL DOSHI, NATHAN DOWDEN, TODD FOLEY, ANJA HARMEIER, PETER KIM, NERISSA KREHER, CAROLE NUECHTERLEIN, KUSH PARMAR, KUSH M. PARMAR, DEHUA PEI, MARIO SALTARELLI, NATARAJAN SETHURAMAN, KORY WENTWORTH

EXECUTIVE OFFICER, DIRECTOR

ENTRADA THERAPEUTICS, INC.

CHRISTINE BRENNAN, JOHN CROWLEY, JOHN F. CROWLEY, DIPAL DOSHI, NATHAN DOWDEN, TODD FOLEY, ANJA HARMEIER, PETER KIM, NERISSA KREHER, CAROLE NUECHTERLEIN, KUSH PARMAR, KUSH M. PARMAR, DEHUA PEI, MARIO SALTARELLI, NATARAJAN SETHURAMAN, KORY WENTWORTH

EXECUTIVE OFFICER

CURE VENTURES FUND I, L.P.

N/A CURE VENTURES FUND I GP, LLC, DAVE FALLACE, RICHARD J. LIM

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D/A

VENTURE CAPITAL FUND

NOT APPLICABLE

2021-05-25

D/A

VENTURE CAPITAL FUND

NOT APPLICABLE

2021-05-25

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2018-12-14

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2018-12-14

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2016-10-27

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2014-09-23

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2011-12-12

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2011-06-30

D/A

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2010-02-17

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2010-02-17